Sanara MedTech (SMTI) Return on Capital Employed (2011 - 2026)

Sanara MedTech has reported Return on Capital Employed for 14 years, with the latest figure at 11.51% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 1027.0% year-over-year to 11.51%; the trailing twelve-month figure through Mar 2026 stood at 11.51% (up 1027.0% YoY), and the FY2025 full-year result was 11.8%, up 989.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 11.51%, up from 8.96% in the prior quarter.
• The five-year high for Return on Capital Employed was 11.51% in Q1 2026, with the low at 17.18% in Q2 2022.
• Historically, Return on Capital Employed has averaged 2.61% across 5 years, with a median of 2.59% in 2023.
• Annual changes were most pronounced in 2023 — Return on Capital Employed jumped 2005 bps — and 2024, when it sank 1001 bps.
• Sanara MedTech's Return on Capital Employed stood at 5.89% in 2022, then slipped by 19 bps to 7.01% in 2023, then surged by 73 bps to 1.89% in 2024, then surged by 575 bps to 8.96% in 2025, then grew by 28 bps to 11.51% in 2026.
• The last three Return on Capital Employed figures came in at 11.51% (Q1 2026), 8.96% (Q4 2025), and 8.87% (Q3 2025), per Business Quant data.